Digitale Posterbegehung am 02.02.2021: Register- und Qualitätsforschung

Was erwartet Sie in dieser Posterbegehung?

Direkt im Anschluss an ein Tutorial ergänzen von 17 bis 18 Uhr thematisch passende und moderierte digitale Posterwalks die Tutorials: Abstracteinreicher präsentieren in Kurzvorträgen ihre Studien- und Forschungsergebnisse aus aktuellen und kürzlich abgeschlossenen Projekten - und Sie stellen Ihre Fragen im Chat.
Moderator*innen dieses Poster-Walks sind: PD Dr. Elisabeth Inwald (Regensburg) und Dr. Christoph Kowalski (Berlin)

  • ID 132: Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany
    Hildraud Kajüter (Bochum)
  • ID 118: Definition and Assessment of Quality Indicators of Sarcoma Work-up using a transdisciplinary real-world digital data platform
    Prof. Dr. Dr. Bruno Fuchs (Luzern)
  • ID 77: A comparison of overall and recurrence free survival after laparoscopic vs open surgery in patients with pelvic and paraaortic lymph node dissection for intermediate and high-risk endometrial cancer
    Dr. Michael Gerken (Regensburg)
  • ID 120: Prognostic value of distinct molecular characteristics for survival in early Colon cancer; real world data from the AIO molecular registry ColoPredict Plus
    Inke Sabine Feder (Bochum)
  • ID 64: Neudiagnose Hodentumor: 30-Monats-Daten aus der nicht-interventionellen, prospektiven Registerstudie VERSUS von d-uo (Deutsche Uro-Onkologen)
    Dr. Jörg Klier (Köln)
  • ID 39: Neudiagnose Urothelkarzinom: 30-Monats-Daten aus der nicht-interventionellen, prospektiven Registerstudie VERSUS von d-uo (Deutsche Uro-Onkologen)
    Dr. Rolf Harald Eichenauer (Hamburg)
  • ID 50: Interdisciplinary "fast track" evaluation: Impact of Optimizing Diagnostic Workup and Reducing of Time to Treatment in Head and Neck Cancer and impact on outcome
    Dr. Cosima Riemenschnitter (Zürich)

Poster

Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany ID 132 Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany Hiltraud Kajüter (Bochum)

Definition and Assessment of Quality Indicators of Sarcoma Work-up using a transdisciplinary real-world digital data platform ID 118 Definition and Assessment of Quality Indicators of Sarcoma Work-up using a transdisciplinary real-world digital data platform Prof. Dr. Bruno Fuchs (Luzern)

A comparison of overall and recurrence free survival after laparoscopic vs open surgery in patients with pelvic and paraaortic lymph node dissection for intermediate and high-risk endometrial cancer ID 77 A comparison of overall and recurrence free survival after laparoscopic vs open surgery in patients with pelvic and paraaortic lymph node dissection for intermediate and high-risk endometrial cancer Dr. Michael Gerken (Regensburg)

Prognostic value of distinct molecular characteristics for survival in early Colon cancer; real world data from the AIO molecular registry ColoPredict Plus ID 120 Prognostic value of distinct molecular characteristics for survival in early Colon cancer; real world data from the AIO molecular registry ColoPredict Plus Inke Sabine Feder (Bochum)

Neudiagnose Hodentumor: 30-Monats-Daten aus der nicht-interventionellen, prospektiven Registerstudie VERSUS von d-uo (Deutsche Uro-Onkologen). ID 64 Neudiagnose Hodentumor: 30-Monats-Daten aus der nicht-interventionellen, prospektiven Registerstudie VERSUS von d-uo (Deutsche Uro-Onkologen). Dr. Jörg Klier (Köln)

Neudiagnose Urothelkarzinom: 30-Monats-Daten aus der nicht-interventionellen, prospektiven Registerstudie VERSUS von d-uo (Deutsche Uro-Onkologen). ID 39 Neudiagnose Urothelkarzinom: 30-Monats-Daten aus der nicht-interventionellen, prospektiven Registerstudie VERSUS von d-uo (Deutsche Uro-Onkologen). Dr. Rolf Harald Eichenauer (Hamburg)

Interdisciplinary "fast track" evaluation: Impact of Optimizing Diagnostic Workup and Reducing of Time to Treatment in Head and Neck Cancer and impact on outcome ID 50 Interdisciplinary "fast track" evaluation: Impact of Optimizing Diagnostic Workup and Reducing of Time to Treatment in Head and Neck Cancer and impact on outcome Dr. Cosima Riemenschnitter (Zürich)